🔎 Trials Near Me

Gara Jalqabaatti › Kansera Urothelial (Cell Transitional) › Arizona › Phoenix

Qorannoo klinikaalii Kansera Urothelial (Cell Transitional) Phoenix, AZ keessatti

Qorannoo 6 Kansera Urothelial (Cell Transitional) f Phoenix fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Exelixis Clinical Site #67, Phoenix
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05176483

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Cancer Center at Saint Joseph's, Phoenix
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06524544

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • Mayo Clinic Hospital in Arizona, Phoenix
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Mayo Clinic Arizona, Phoenix
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07277413

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

Namoota walitti qabaa jiraSadarkaa 2/3
  • Research Site, Phoenix
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07815665

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Mayo Clinic Comprehensive Cancer Center, Phoenix
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT07169734

Qorannoo Kansera Urothelial (Cell Transitional) magaalota biroo keessatti

Qorannoo biroo Phoenix keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.